Fusion Pharmaceuticals Appoints Donald Bergstrom, M.D., Ph.D., to Board of Directors
Canada NewsWire HAMILTON , ON and BOSTON , April 1, 2021 /CNW/ — Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company
Read moreCanada NewsWire HAMILTON , ON and BOSTON , April 1, 2021 /CNW/ — Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company
Read moreCanada NewsWire Net Cash Used in Operating Activities (Total Cash Burn) of $24.2 million USD ( $30.5 million CAD) for
Read more–Retrospective analyses of the Phase 3 SIMPLIFY studies demonstrate safety and activity profile are not impacted by baseline platelet count–
Read moreBOSTONand MONTRÉAL,Dec. 3, 2020/CNW Telbec/ – enGene Inc., a biotechnology company developing non-viral gene therapies for local administration into mucosal tissues enabled
Read moreEisai and Wren Therapeutics Enter Into Research Collaboration Agreement for Drug Discovery for Synucleinopathies TOKYO, Nov 30, 2020 – (JCN
Read moreCanada NewsWire VICTORIA, BC, Nov. 23, 2020 VICTORIA, BC,Nov. 23, 2020/CNW/ – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSX VENTURE:
Read more